Literature DB >> 10732894

Serum neopterin and complex stenosis morphology in patients with unstable angina.

X Garcia-Moll1, F Coccolo, D Cole, J C Kaski.   

Abstract

OBJECTIVES: We sought to assess the relation between serum neopterin concentration and complex coronary artery stenosis in patients with unstable angina.
BACKGROUND: Monocyte activation is associated with acute atheromatous plaque disruption and acute coronary syndromes. Angiographically demonstrated complex coronary stenosis is often an expression of plaque disruption. Increased serum concentration of neopterin, a pterydine derivative secreted by macrophages after stimulation by interferon-gamma, has been observed in patients with acute coronary syndromes as compared with control subjects and patients with stable angina pectoris.
METHODS: We studied 50 patients with unstable angina (32 men) who underwent coronary angiography after hospital admission. All coronary stenoses with > or =30% diameter reduction were assessed and classified as "complex" (irregular or scalloped borders, ulceration or filling defects suggesting thrombi) or "smooth" (absence of complex features). Serum neopterin levels were assessed within 24 h of hospital admission using a commercially available immunoassay (enzyme-linked immunosorbent assay kit, IBL, Hamburg, Germany).
RESULTS: Thirty-nine patients were classified in Braunwald class IIIb, four in class IIb and seven in class Ib. The number of complex lesions per patient was 2.6+/-1.8 (mean +/- SD). The mean neopterin concentration was 7.76+/-3.62 nmol/liter. A significant correlation was observed between neopterin serum concentration and the presence of complex coronary stenoses (r = 0.35, p = 0.015). Multiple regression analysis showed that serum neopterin (p < 0.0001) was independently associated with the number of complex lesions. Other variables associated with complex lesions were the number of vessels with > or =75% stenosis (p < 0.0001), plasma creatinine (p = 0.003), triglycerides (p = 0.014) and a history of unstable angina (p = 0.032).
CONCLUSIONS: Serum neopterin concentration is associated with the presence of angiographically demonstrated complex lesions in patients with unstable angina and may represent a marker of coronary disease activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10732894     DOI: 10.1016/s0735-1097(99)00640-3

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

1.  Circulating monocytes in patients with acute coronary syndromes lack sufficient interleukin-10 production after lipopolysaccharide stimulation.

Authors:  P L van Haelst; J W Cohen Tervaert; J Bijzet; C Baljé-Volkers; J F May; B Langeveld; R O B Gans
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

2.  Neopterin is associated with plaque inflammation and destabilisation in human coronary atherosclerotic lesions.

Authors:  T Adachi; T Naruko; A Itoh; R Komatsu; Y Abe; N Shirai; H Yamashita; S Ehara; M Nakagawa; C Kitabayashi; Y Ikura; M Ohsawa; M Yoshiyama; K Haze; M Ueda
Journal:  Heart       Date:  2007-06-17       Impact factor: 5.994

3.  Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes.

Authors:  P Avanzas; R Arroyo-Espliguero; J Cosín-Sales; G Aldama; C Pizzi; J Quiles; J C Kaski
Journal:  Heart       Date:  2004-08       Impact factor: 5.994

4.  Evaluation of serum neopterin, high-sensitivity C-reactive protein and thiobarbituric acid reactive substances in Egyptian patients with acute coronary syndromes.

Authors:  M Ragab; H Hassan; T Zaytoun; W Refai; B Rocks; M Elsammak
Journal:  Exp Clin Cardiol       Date:  2005

Review 5.  Potential to inhibit growth of atherosclerotic plaque development through modulation of macrophage neopterin/7,8-dihydroneopterin synthesis.

Authors:  S P Gieseg; E M Crone; E A Flavall; Z Amit
Journal:  Br J Pharmacol       Date:  2007-08-13       Impact factor: 8.739

6.  Association between serum neopterin and inflammatory activation in chronic kidney disease.

Authors:  Ashok Kumar Yadav; Vinod Sharma; Vivekanand Jha
Journal:  Mediators Inflamm       Date:  2012-08-26       Impact factor: 4.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.